Premium
The C allele of the GNB3 C825T polymorphism of the G protein β3‐subunit is associated with an increased risk for the development of oncocytic thyroid tumours
Author(s) -
Sheu SY,
Handke S,
BröckerPreuss M,
Görges R,
Frey UH,
Ensinger C,
Öfner D,
Farid NR,
Siffert W,
Schmid KW
Publication year - 2007
Publication title -
the journal of pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.964
H-Index - 184
eISSN - 1096-9896
pISSN - 0022-3417
DOI - 10.1002/path.2084
Subject(s) - thyroid , medicine , endocrinology , genotype , follicular cell , biology , allele , thyroid carcinoma , gene , genetics
Abstract Carriers of the C allele of the common C825T polymorphism in the GNB3 gene of the G protein have been associated with the development of follicular thyroid adenomas. Since the C allele of this polymorphism is related to a lower signalling capacity, it was speculated whether the C825T polymorphism may play a particular role in oncocytic thyroid tumours, which are recognized for their reduced ability to synthesize thyroid‐specific proteins and hormones, although they possess an intact thyroid‐stimulating hormone receptor–adenylyl cyclase system. Using pyrosequencing, both the genotype distribution and the allele frequency of the C825T polymorphism were investigated in a series of 104 patients with oncocytic thyroid tumours of follicular cell origin [58 adenomas, 41 follicular thyroid carcinomas (FTCs), and five papillary thyroid carcinomas (PTCs)]; the results were compared with those obtained from 321 age and gender‐matched healthy blood donors and a series of 327 non‐oncocytic thyroid tumours of follicular cell origin (119 adenomas, 80 FTCs, and 186 PTCs). Analysis of the genotype distribution (comparing oncocytic with non‐oncocytic tumours of the present series) revealed a significantly increased odds ratio (OR) for CC versus TT (OR = 4.22; p = 0.011) and CC versus CT (OR = 1.62; p = 0.049) carriers to develop an oncocytic thyroid tumour; ORs to develop an oncocytic thyroid tumour were also increased comparing the genotype distribution between the group of oncocytic tumours and healthy controls for CC versus TT (OR = 3.73; p = 0.017) and CC versus all T carriers (OR = 1.56; p = 0.034). Oncocytic thyroid tumours as a group showed a statistically significant increase of the C‐allele frequency when compared with all non‐oncocytic tumours ( p = 0.0039) as well as healthy blood donors ( p = 0.017). The results strongly suggest that the C allele of the GNB3 C825T polymorphism of the G protein β3‐subunit is associated with an increased risk for the development of oncocytic thyroid tumours. This polymorphism may thus be considered a (co)factor favouring the development of oncocytic thyroid tumours, although the biological mechanism(s) underlying this association remain obscure. Copyright © 2006 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.